Related Experiment Video
Updated: Oct 25, 2025
07:50
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
2.9K
Dual-Frequency Intravascular Sonothrombolysis: An In Vitro Study
Summary
Dual-frequency sonothrombolysis using microbubbles significantly enhances clot lysis. This intravascular ultrasound technique offers a more effective treatment for thrombo-occlusive disease compared to single-frequency methods.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Acoustic Cavitation
Background:
- Thrombo-occlusive disease is a major global health concern.
- Sonothrombolysis with microbubbles (MBs) shows promise for clot dissolution.
- Dual-frequency sonothrombolysis may improve efficacy, especially for intravascular applications.
Purpose of the Study:
- To investigate the efficacy of dual-frequency intravascular sonothrombolysis.
- To develop and test a broadband intravascular ultrasound transducer for this application.
- To optimize dual-frequency parameters for enhanced clot lysis.
Main Methods:
- Designed and fabricated a 750 kHz broadband intravascular ultrasound transducer.
- Conducted in vitro sonothrombolysis experiments using a flow model.
- Evaluated dual-frequency (750 kHz + variable second frequency) sonothrombolysis with MBs.
Main Results:
- The developed transducer exhibited a 68.1% fractional bandwidth and 1.5 MPa peak negative pressure.
- Dual-frequency (750+500 kHz) sonothrombolysis achieved an 85% higher lysis rate than single-frequency treatment.
- Lysis rate increased with the frequency difference in dual-frequency sonothrombolysis.
Conclusions:
- Dual-frequency intravascular sonothrombolysis with MBs is more effective than single-frequency methods.
- The developed broadband transducer supports efficient dual-frequency operation.
- This technique holds potential for improved treatment of thrombo-occlusive diseases.
